J Pathol Transl Med.  2018 Jan;52(1):67-70. 10.4132/jptm.2017.11.09.

An Extremely Rare Case of Back and Hip Pain due to the Metastasis of Late Recurrent Myxopapillary Ependymoma to the Inguinal Lymph Node

Affiliations
  • 1Laboratory of Acibadem Pathology, Department of Acibadem University Medical Faculty, Istanbul, Turkey. suheylaekemen@gmail.com
  • 2Department of Pathology, Acibadem University Medical Faculty, Istanbul, Turkey.
  • 3Department of General Surgery, Acibadem University Medical Faculty, Istanbul, Turkey.

Abstract

No abstract available.


MeSH Terms

Ependymoma*
Hip*
Lymph Nodes*
Neoplasm Metastasis*

Figure

  • Fig. 1. Metastatic tumor in the lymph node. (A) In the lower-left corner is a normal lymph node structure; in the remaining areais the metastasis. (B, C) Higher magnification view of the metastasiscystic and papillary structures (B) with a single-row cuboidal-columnar epithelium in the myxoid and vascularized stroma (arrows) (C). Lumens contain mucinous material.

  • Fig. 2. Histopathological findings suggest that the tumor is originated from the central nervous system, consistent with myxopapillary ependymoma metastasis. (A) Periodic acid-Shiff–Alcian blue histochemical stain shows the presence of acidic mucin. (B) Epidermal growth factor receptor positivity of the tumor cells by immunohistochemistry (IHC). (C) Glial fibrillary acidic protein positivity of the tumor cells by IHC. (D) Vimentin positivity of the tumor cells by IHC.


Reference

1. Weber DC, Wang Y, Miller R, et al. Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol. 2015; 17:588–95.
Article
2. Wang H, Zhang S, Rehman SK, et al. Clinicopathological features of myxopapillary ependymoma. J Clin Neurosci. 2014; 21:569–73.
Article
3. Satti M, Firoze M, Malaker K, Hussain M, Maniyar I. Mediastinal myxopapillary ependymoma primary or late metastases of paracoccygeal ependymoma: a case report. Ann Diagn Pathol. 2005; 9:215–8.
Article
4. Fujimori T, Iwasaki M, Nagamoto Y, Kashii M, Sakaura H, Yoshikawa H. Extraneural metastasis of ependymoma in the cauda equina. Global Spine J. 2013; 3:33–40.
Article
5. Kramer GW, Rutten E, Sloof J. Subcutaneous sacrococcygeal ependymoma with inguinal lymph node metastasis: case report. J Neurosurg. 1988; 68:474–7.
6. Lee KJ, Min BW, Seo HJ, Cho CH. Subcutaneous sacrococcygeal myxopapillary ependymoma in asian female:a case report. J Clin Med Res. 2012; 4:61–3.
7. Wight DG, Holley KJ, Finbow JA. Metastasizing ependymoma of the cauda equina. J Clin Pathol. 1973; 26:929–35.
Article
8. Helwig EB, Stern JB. Subcutaneous sacrococcygeal myxopapillary ependymoma: a clinicopathologic study of 32 cases. Am J Clin Pathol. 1984; 81:156–61.
Article
9. Bardales RH, Porter MC, Sawyer JR, Mrak RE, Stanley MW. Metastatic myxopapillary ependymoma: report of a case with fine-needle aspiration findings. Diagn Cytopathol. 1994; 10:47–53.
Article
10. Vega-Orozco R, Rembao-Bojórquez D, Salmerón-Mercado M, García-Marquez A, Tena-Suck ML. Inguinal lymph nodal metastasis of myxopapillary ependymoma confirmed by fine-needle aspiration cytology, biopsy, and immunohistochemistry: case report. Diagn Cytopathol. 2011; 39:689–93.
Article
Full Text Links
  • JPTM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr